Buserelin is a synthetic decapeptide used in the treatment of prostate cancer and endometriosis. During its production, impurities may be introduced, which can affect its purity and quality. These impurities can include related substances, degradation products, and residual solvents. Accurate identification and quantification of these impurities is important to ensure the safety and efficacy of the drug product.
